1. Home
  2. ANGI vs GALT Comparison

ANGI vs GALT Comparison

Compare ANGI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$5.59

Market Cap

255.2M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.54

Market Cap

297.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
GALT
Founded
1995
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.2M
297.0M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
ANGI
GALT
Price
$5.59
$3.54
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$17.00
$8.50
AVG Volume (30 Days)
625.1K
1.0M
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
36.84
EPS
N/A
N/A
Revenue
$736,386,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.60
N/A
52 Week Low
$4.53
$2.03
52 Week High
$19.42
$7.13

Technical Indicators

Market Signals
Indicator
ANGI
GALT
Relative Strength Index (RSI) 45.40 45.02
Support Level $4.67 $2.30
Resistance Level $6.56 $4.35
Average True Range (ATR) 0.33 0.49
MACD -0.08 -0.18
Stochastic Oscillator 29.67 9.01

Price Performance

Historical Comparison
ANGI
GALT

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: